Laurie J. Olson - 03 Jan 2023 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Jan 2023
Net transactions value
-$112,620
Form type
4
Filing time
05 Jan 2023, 15:39:14 UTC
Previous filing
12 Oct 2022
Next filing
05 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $84,860 +1,000 $84.86 1,000 03 Jan 2023 Direct
transaction KRTX Common Stock Sale $197,480 -1,000 -100% $197.48 0 03 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -1,000 -6.2% $0.000000 15,000 03 Jan 2023 Common Stock 1,000 $84.86 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2022.
F2 This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020.